TABLE 2.
Comparison of patient backgrounds between the DPPHR and PD groups after propensity score matching
| DPPHR (n = 25) | PD (n = 25) | P‐value | |
|---|---|---|---|
| Preoperative variables | |||
| Age (y) | 62.8 ± 11.3 | 64.2 ± 10.6 | .698 |
| Gender (male/female) | 15/10 | 16/9 | .771 |
| Body mass index | 21.0 ± 3.0 | 23.1 ± 3.3 | .064 |
| Diagnosis (IPMN/NEN/SPN/SCN/others) | 20/4/1/0/0 | 21/2/0/1/1 | .151 |
| CT attenuation value (HU) | 57.8 ± 5.7 | 61.8 ± 7.6 | .128 |
| Albumin | 4.2 ± 0.31 | 4.3 ± 0.4 | .651 |
| Total lymphocyte count | 1524 ± 532 | 1675 ± 653 | .378 |
| Hemoglobin | 13.7 ± 1.5 | 13.4 ± 1.3 | .289 |
| Prognostic nutrition index | 47.5 ± 10.7 | 49.9 ± 4.8 | .698 |
| Aspartate aminotransferase (AST) (IU/L) | 23.4 ± 10.7 | 21.4 ± 6.4 | .425 |
| Alanine transaminase (ALT) (IU/L) | 20.0 ± 8.7 | 19.3 ± 6.9 | .992 |
| Platelet count (103/μL) | 207 ± 66 | 234 ± 122 | .248 |
| FIB‐4 index | 1.72 ± 0.68 | 1.63 ± 0.98 | .327 |
| Intraoperative variables | |||
| Operative time (min) | 447 ± 80 | 491 ± 237 | .788 |
| Blood loss (g) | 375 ± 323 | 327 ± 264 | .549 |
| Postoperative variables | |||
| Clinically relevant pancreatic fistula (%) | 16.0% (4/25) | 28.0% (7/25) | .306 |
| Complication with Clavien–Dindo grade ≥3 (%) | 28% (7/25) | 40% (10/25) | .370 |
| Postoperative exocrine enzyme supplementation (yes/no) | 25/0 | 23/2 | .478 |
Abbreviations: DPPHR, duodenum‐preserving pancreatic head resection; Fib‐4:Fibrosis‐4; HU, Hounsfield Unit; IPMN, intraductal papillary mucinous neoplasm; NEN, neuroendocrine neoplasm; PD, pancreaticoduodenectomy; SCN, serous cystic neoplasm; SPN, solid pseudopapillary neoplasm.